0000000000640623

AUTHOR

Di Leonardo A

showing 2 related works from this author

Expression of the kinetochore protein Hec1 during the cell cycle in normal and cancer cells and its regulation by the pRb pathway.

2010

Highly Expressed in Cancer protein 1 (Hec1) is a subunit of the Ndc80 complex, a constituent of the mitotic kinetochore. HEC1 has been shown to be overexpressed in many cancers, suggesting that HEC1 upregulation is involved in the generation and/or maintenance of the tumour phenotype. However, the regulation of Hec1 expression in normal and tumour cells and the molecular alterations promoting accumulation of this protein in cancer cells are still unknown. Here we show that elevated Hec1 protein levels are characteristic of transformed cell lines of different origins and that kinetochore recruitment of this protein is also increased in cancer cell lines in comparison with normal human cells.…

Cyclohexamide CHXRetinoblastoma ProteinCell Line TumorNeoplasmsmedicineHumansGene silencingGene SilencingNuclear proteinKinetochoresMolecular BiologyMitosisHec1biologyCell CycleRetinoblastoma proteinNuclear ProteinsCancerCell BiologyCell cyclemedicine.diseaseCell biologyCytoskeletal ProteinsSettore BIO/18 - GeneticaMitotic exitCancer cellbiology.proteinRNA InterferenceSignal TransductionDevelopmental Biologymicrotubule
researchProduct

Investigating CRISPR-CAS13b as a tool for the RNA editing of CFTR mRNA with premature stop codon

2020

Background and Rationale Some CF patients are compound heterozygous or homozygous for nonsense mutations in the CFTR gene. Mutant CFTR gene coding for transcripts with premature termination codons (PTCs) is responsible for truncated CFTR protein and for a severe form of the disease. In a precision medicine framework the “REPAIRv2” (RNA Editing for Programmable A to I Replacement v2) tool, developed in the laboratory of Dr. Feng Zhang (USA), seems a good alternative to restore the full-length CFTR protein by editing its mRNA containing PTCs. This new approach is based on the possibility of targeting a deaminase enzyme (huADAR2) to a specific Adenosine, to be edited to Inosine (G analogue), o…

Settore BIO/18 - GeneticamRNA editing CFTR CRISPR-dCAS13b
researchProduct